Adherence to Secondary Prevention Guidelines for Cardiovascular Risk

Recruiting

• Conditions: Ischemic Heart Disease; Atherosclerosis; Stroke, Ischemic; Peripheral Arterial Disease; Acute Coronary Syndrome
• Interventions: Other: cardiovascular event

• Registration Number: NCT06450561
• Lead Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf

Brief Summary

The present observational study aims to determine the degree of adherence to the recommendations of clinical guidelines regarding the prevention of cardiovascular complications in patients hospitalized due to a cardiovascular event.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-03-01
• Study First Submitted: 2024-06-03
• Study First Submitted QC: 2024-06-07
• Study First Posted: 2024-06-10
• Status Verified: 2025-01
• Last Update Submitted: 2025-02-10
• Last Update Posted: 2025-02-12
• Primary Completion: 2025-06
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 410

Inclusion Criteria

• Admitted to the cardiology, neurology, or general surgery departments
• With any of the following admission diagnoses:

Non-ST-segment elevation acute coronary syndrome (NSTEACS) ST-segment elevation acute coronary syndrome (STEACS) Stable angina Unstable angina Non-ST-segment elevation myocardial infarction (NSTEMI) ST-segment elevation myocardial infarction (STEMI) Atherothrombotic ischemic stroke Lacunar stroke Peripheral artery disease Chronic ischemia of lower limbs Vascular ulcer due to arterial cause

Exclusion Criteria

• Patients for whom lipid-lowering treatment is ruled out due to limited life expectancy
• Patients likely to die during hospitalization
• Patients who died during hospitalization

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients hospitalized due to a cardiovascular event	cardiovascular event	Patients hospitalized due to a cardiovascular event including stroke, acute coronary syndrome, ischemic heart disease, or peripheral arterial disease

Primary Outcome Measures

Name	Time	Method
patients admitted for a cardiovascular event who are prescribed lipid-lowering treatment at discharge	At hospital discharge	Proportion of patients admitted for a cardiovascular event, warranting the initiation of secondary prevention with lipid-lowering agents, who are prescribed lipid-lowering treatment at discharge, adequate to reduce LDL by 50% or to below 55 mg/dL

Trial Locations

Locations (1)

Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil; 🇪🇸 Sant Pere De Ribes, Barcelona, Spain